Navigation Links
Isis Initiates Phase 1 Studies with Isis-GCGRRx and Isis-GCCRRx to Treat Type 2 Diabetes
Date:11/2/2011

ovascular, metabolic and severe and rare/neurodegenerative diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, mipomersen, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT

This press release includes forward-looking statements regarding Isis Pharmaceuticals and the discovery, development and potential of ISIS-GCGRRx and ISIS-GCCRRx for the treatment of type 2 diabetes.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of mipomersen, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2010 and its most recent quarterly report on Form 10-Q, which are on file with the SEC. Copies of these and other document
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
2. Elusys Initiates Third Clinical Safety Study of Anthim, a New Anthrax Treatment; Company Successfully Completes Manufacturing at Commercial Scale
3. CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam®
4. CareFusion Initiates Class I Recall of EnVe Ventilators
5. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
6. ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis
7. Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients
8. Adamas Pharmaceuticals Initiates a Phase 2/3 Clinical Study of ADS-5102 for Parkinsons Disease
9. Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes
10. Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain
11. Omthera Pharmaceuticals, Inc. Initiates Phase III ESPRIT Trial of Add-on Epanova™ to Statin Therapy in Patients with Hypertriglyceridemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... Research and Markets ( ... "North American Active Wound Care Market by ... & Ulcer), by End-User (In-Patient, & Out-Paient) - ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The North ... grow at a CAGR of 3.1% from 2014 ...
(Date:5/21/2015)... Calif. , May 21, 2015  Cardica, Inc. (Nasdaq: ... new employee Greg Watson , the company,s vice president ... of the company,s common stock, at a per share exercise ... 2015. The stock option was granted pursuant to Cardica, Inc.,s ... directors in May 2015 under Rule 5653(c)(4) of the Nasdaq ...
(Date:5/21/2015)... England , May 21, 2015 ... Bekämpfung von Arzneimittelfälschungen - Zwecks Leistungsvergleich ... Arzneimittelprüfdienstes wird auf EG-Mitgliedstaaten verwiesen, in ... betrieben werden.  Wählen Sie ein Aegate-Land: ... der Richtlinie zur Bekämpfung von Arzneimittelfälschungen ...
Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3
... Corporate Affairs – also called Public Affairs ... key success drivers for organizations. In many organizations, ... Government Affairs, Corporate Communications and Patient Advocacy – ... interactions with important external and internal partners. ...
... Nov. 5, 2010 Will power wheelchairs continue ... of federal regulatory and policy changes? There are ... providers in Nevada that the changes in Medicare policies may ... and services to beneficiaries. One of the ...
Cached Medicine Technology:Corporate Affairs Role in Internal and External Relationships Key to Organizational Success 2Medicare Policy Changes Will Make it More Difficult for Nevada Beneficiaries to Obtain Power Wheelchairs 2Medicare Policy Changes Will Make it More Difficult for Nevada Beneficiaries to Obtain Power Wheelchairs 3Medicare Policy Changes Will Make it More Difficult for Nevada Beneficiaries to Obtain Power Wheelchairs 4
(Date:5/22/2015)... Ticket Down is a reputable source for ... Eastern Conference Finals Tickets . All seating for the ... the ticket listing. , For the first time in ... of the Eastern Conference. One of the original franchises in ... and downs over the years, but the excitement level for ...
(Date:5/22/2015)... May 22, 2015 Steven Winter Associates ... Zuluaga, has been selected by Consulting-Specifying Engineer (CSE) magazine ... winners are featured in the May/June issue of the ... industry professionals age 40 and younger who have, and ... as well as in other areas of their professional ...
(Date:5/22/2015)... Chicago, IL (PRWEB) May 22, 2015 Co ... whose purpose is to allow general dentists to immediately deliver ... concept is based on that of the medical surgeon. ... addresses six main roadblocks preventing general dentists from placing dental ... taking the necessary steps to introduce the surgical placement of ...
(Date:5/22/2015)... Bryce Henson, local fitness icon and owner ... recently accepted his program’s 100th client. Henson says that ... his location evidences the powerful impact his boot camp ... Boot Camp is the nation’s most popular and fastest ... locations across North America, Europe and Australia. Anaheim Fit ...
(Date:5/22/2015)... 22, 2015 In efforts to offer ... section containing particular muscles stretches has been a large ... of stretches now complete, Chunk Fitness envisions a mid-June ... be filmed and released at a later point in ... here: http://www.chunkfitness.com/stretches . , About the Company: Chunk ...
Breaking Medicine News(10 mins):Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2Health News:Healthy Living Brought to Anaheim— New Fitness Boot Camp Acquires 100 Clients 2
... HealthDay Reporter , MONDAY, March 19 (HealthDay News) -- ... treat hernias results in less chronic pain and a faster ... however, said the older strategy may still be the best ... L. Michael Brunt, a professor at Washington University in St. ...
... past decade, scientists have made significant progress building the ... novel tuberculosis (TB) vaccine candidates and move the most ... those trials, coupled with advances from other TB studies, ... of research on TB vaccines, a critical component of ...
... MONDAY, March 19 (HealthDay News) -- If your blood pressure ... or woozy, you may be at greater risk for developing ... known as orthostatic hypotension. According to the study, people with ... failure than their counterparts who did not develop low blood ...
... MONDAY, March 19 (HealthDay News) -- Sex may not ... that some women can also experience the sensation while ... to as a "coregasm" because of its association with ... Debby Herbenick, co-director of the Center for Sexual Health ...
... MONDAY, March 19 (HealthDay News) -- Medicaid patients have more ... often than those with private insurance, a new study finds. ... who took part in the U.S. National Health Interview Survey ... Medicaid beneficiaries had one or more barriers to primary care, ...
... and are notoriously resistant to treatment, making them among the ... from a unique biological barrier the tumor builds around itself. ... found a way to break through that defense, and their ... cancer. , In a paper to be published in ...
Cached Medicine News:Health News:Less Invasive Hernia Procedure Easier on Patients: Study 2Health News:NIH researchers highlight progress, path forward for developing TB vaccines 2Health News:Lightheadedness Upon Standing Could Signal Heart Risk 2Health News:Lightheadedness Upon Standing Could Signal Heart Risk 3Health News:Exercise May Trigger Orgasm in Some Women 2Health News:Medicaid Patients Go to ERs More Often: Study 2Health News:Hutchinson Center scientists break through pancreas cancer treatment barrier 2Health News:Hutchinson Center scientists break through pancreas cancer treatment barrier 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: